Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 133.33 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $61.90 million which beat the analyst consensus estimate of $58.07 million by 6.59 percent. This is a 8.45 percent decrease over sales of $67.61 million the same period last year.